Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
59
DVA Quote, Financials, Valuation and Earnings
Last price:
$151.82
Seasonality move
:
2.92%
Day range:
$146.34 - $149.95
52-week range:
$101.00 - $159.27
Dividend yield:
0%
P/E ratio:
15.59x
P/S ratio:
0.83x
P/B ratio:
95.39x
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-15.88%
Market cap:
$10B
Revenue:
$13.6B
EPS (TTM):
$9.56
Analysts' Opinion
-
Consensus RatingDaVita, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $151.71, DaVita, Inc. has an estimated upside of 1.86% from its current price of $148.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $126.00 representing -- downside risk from its current price of $148.95.
Fair Value
-
According to the consensus of 7 analysts, DaVita, Inc. has 1.86% upside to fair value with a price target of $151.71 per share.
DVA vs. S&P 500
-
Over the past 5 trading days, DaVita, Inc. has overperformed the S&P 500 by 1.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DaVita, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DaVita, Inc. has grown year-over-year revenues for 12 quarters straight. In the most recent quarter DaVita, Inc. reported revenues of $3.6B.
Earnings Growth
-
DaVita, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter DaVita, Inc. reported earnings per share of $2.94.
Enterprise value:
24.1B
EV / Invested capital:
0.00x
Price / LTM sales:
0.83x
EV / EBIT:
11.97x
EV / Revenue:
1.76x
PEG ratio (5yr expected):
2.44x
EV / Free cash flow:
18.34x
Price / Operating cash flow:
8.62x
Enterprise value / EBITDA:
8.83x
Gross Profit (TTM):
$3.7B
Return On Assets:
5.97%
Net Income Margin (TTM):
7.72%
Return On Equity:
67.52%
Return On Invested Capital:
7.44%
Operating Margin:
15.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $12.1B | $12.8B | $13.6B | $3.3B | $3.6B | |
| Gross Profit | $3.1B | $3.5B | $3.7B | $895.2M | $1B | |
| Operating Income | $1.6B | $2B | $2B | $480.7M | $551.2M | |
| EBITDA | $2.3B | $2.7B | $2.7B | $654.8M | $737.9M | |
| Diluted EPS | $7.41 | $10.75 | $9.56 | $3.09 | $2.94 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.2B | $3.2B | $3.1B | $3.7B | $4.1B | |
| Total Assets | $17.9B | $17.7B | $17.6B | $18B | $18.1B | |
| Current Liabilities | $2.4B | $2.6B | $2.6B | $3B | $3.1B | |
| Total Liabilities | $15.5B | $15.5B | $14.9B | $15.9B | $17B | |
| Total Equity | $2.4B | $2.2B | $2.7B | $2.1B | $1.2B | |
| Total Debt | $11.6B | $11.4B | $10.7B | $11.7B | $12.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.1B | $2B | $1.9B | $547.8M | $540.8M | |
| Cash From Investing | -$723.5M | -$816.7M | -$671.6M | -$257.4M | -$166.1M | |
| Cash From Financing | -$1.2B | -$778.3M | -$1.4B | -$555.8M | -$411.6M | |
| Free Cash Flow | $1.5B | $1.5B | $1.3B | $377.1M | $395.3M | |
DVA
Sector
Market Cap
$10B
$24M
Price % of 52-Week High
--
48.29%
Dividend Yield
0%
0%
Shareholder Yield
20.47%
-1.6%
1-Year Price Total Return
-15.88%
-22.92%
Beta (5-Year)
0.994
0.500
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$144.03
200-day SMA
Buy
Level
$130.07
Bollinger Bands (100)
Buy
Level
111.16 - 131.68
Chaikin Money Flow
Buy
Level
248.1M
20-day SMA
Buy
Level
$123.30
Relative Strength Index (RSI14)
Buy
Level
73.06
ADX Line
Buy
Level
41.27
Williams %R
Sell
Level
-7.8233
50-day SMA
Buy
Level
$118.08
MACD (12, 26)
Buy
Level
9.56
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
317.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4308)
Sell
CA Score
(Annual)
Level (-2.029)
Buy
Beneish M-Score
(Annual)
Level (-2.6911)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.8262)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Stock Forecast FAQ
In the current month, DVA has received 1 Buy ratings 6 Hold ratings, and 0 Sell ratings. The DVA average analyst price target in the past 3 months is $151.71.
-
Where Will DaVita, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that DaVita, Inc. share price will rise to $151.71 per share over the next 12 months.
-
What Do Analysts Say About DaVita, Inc.?
Analysts are divided on their view about DaVita, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DaVita, Inc. is a Sell and believe this share price will drop from its current level to $126.00.
-
What Is DaVita, Inc.'s Price Target?
The price target for DaVita, Inc. over the next 1-year time period is forecast to be $151.71 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is DVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DaVita, Inc. is a Hold. 6 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of DVA?
You can purchase shares of DaVita, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DaVita, Inc. shares.
-
What Is The DaVita, Inc. Share Price Today?
DaVita, Inc. was last trading at $151.82 per share. This represents the most recent stock quote for DaVita, Inc.. Yesterday, DaVita, Inc. closed at $148.95 per share.
-
How To Buy DaVita, Inc. Stock Online?
In order to purchase DaVita, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get DVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DVA
Sector
P/E ratio
15.59x
23.25x
PEG ratio
2.44x
-0.01x
P/B ratio
95.39x
1.73x
Price / LTM sales
0.83x
1.51x
Growth Metrics
DVA
Sector
Revenue growth
9.87%
3.51%
Earnings growth
-5.07%
11.14%
Revenue (5-year growth)
3.39%
6.27%
Earnings forecast
$3.19
-$0.19
Profitability
DVA
Sector
Profitability FY 2025
$3.7B
$2.7M
Return on invested capital
7.44%
-33.58%
Return on assets
5.97%
-29.74%
Return on equity
67.52%
-38.98%
Earnings Date
Last Earnings Date
Feb
2
Next Earnings Date
May
4
Estimated Next Earnings Date
May
4
Balance Sheet
DVA
Sector
Total cash
$782.1M
$24.9M
Short term investments
$51.1M
$23.9M
Total assets
$18.1B
$71.6M
Long term debt
$12.4B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 17
Cooper-Standard Holdings, Inc. [CPS] is up 0.51% over the past day.
Buy
58
TPH alert for Feb 17
Tri Pointe Homes, Inc. [TPH] is down 0.15% over the past day.
Sell
20
IRON alert for Feb 17
Disc Medicine, Inc. [IRON] is up 15.42% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
